Profound® Treatment References

1. Berube D. Real-time temperature feedback for clinical reproducibility: the mechanism of action of Profound. 2015. Candela, data on file.
2. Alexiades-Armenakas / Dermatol Surg. 2012/p8/col 2/para 1/ln 4-12
3. Hantash BM, Ubeid AA, Chang H, Kafi R, Renton B. Bipolar fractional radiofrequency treatment induces neoelastogenesis and neocollagenesis. Lasers Surg Med. 2009;41(1):1-9
4. Alexides-Armenakas M, Rosenberg D, Renton B, et al. Blinded, randomized, quantitative grading comparison of minimally invasive, fractional radiofrequency and surgical face-lift to treat skin laxity. Arch Dermatol. 2010;146(4):396-405.
5. Profound 510(k) clearance (K161043), September 2016.
6. Willey A, Kilmer S, Newman J, et al. Elastometry and clinical results after bipolar radiofrequency treatment of skin. Dermatol Surg. 2010;36(6):877-884.
7. Alexiades M, Berube D. Randomized, blinded, 3-arm clinical trial assessing optimal temperature and duration for treatment with minimally invasive fractional radiofrequency. Dermatol Surg. 2015;41(5):623-632.
8. Alexiades-Armenakas M, Newman J, Willey A, et al. Prospective multicenter clinical trial of a minimally invasive temperature-controlled bipolar fractional radiofrequency system for rhytid and laxity treatment. Dermatol Surg. 2013;39(2):263-273.
9. McIntosh J. Collagen: what is it and what are its uses? Medical News Today website. Accessed November 13, 2018.
10. Elastin (medical definition). MedicineNet website. Accessed November 13, 2018.
11. Hyaluronic acid (medical definition). MedicineNet website. Accessed November 13, 2018.
12. Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: a key molecule in skin aging. Dermatoendocrinol. 2012;4(3):253-258.